SSII · XBRL financial data

SS Innovations International financial statements, every quarter

The same tables from 17 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work
  • Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
  • Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
  • * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
  • 0 means a filing states zero; a dash (—) means no filing states that number.
  • “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
  • Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
  • Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
  • Shares outstanding come from each filing's cover page, as of the date printed there.
  • Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

CSV

Fiscal quarters (SSII's year ends in late December)

In thousands of dollarsSep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
Revenue2,1871,426*3,6384,5094,3878,116*5,12110,00012,82914,534*11,101—
Revenue from contracts with customers—year only——————————
Cost of revenue1,8881,845*2,9103,0712,0694,147*4,0334,0856,6648,157*5,7746,839
Gross profit299(419)*7281,4382,3173,969*1,0875,9156,1656,377*5,3277,101
Research and development292278*528759443762*1,0104997861,391*9952,396
Selling, general and administrative1,7961,725*2,8442,2452,5082,561*3,4113,4294,8223,388*4,5024,452
Total operating expenses2,15111,741*10,5615,5385,5225,808*7,0095,8188,0007,112*8,9669,372
Operating income (loss)(1,852)(12,160)*(9,832)(4,100)(3,205)(1,839)*(5,922)97(1,835)(735)*(3,639)(2,271)
Interest income—————————year only25—
Interest expense135498*183243248293*380217177335*284345
Other income (expense)88156*181—————————
Income tax expense (benefit)———————3541,8471,766*151505
Net income (loss)(1,899)(12,142)*(9,842)(4,141)(3,245)(1,923)*(5,681)(257)(3,718)(2,471)*(3,583)(2,661)
Earnings per share, basic USD per share(0.01)—(0.06)(0.02)(0.02)(0.01)*(0.03)0.00(0.02)(0.01)*(0.02)(0.01)
Earnings per share, diluted USD per share(0.01)—(0.06)(0.02)(0.02)(0.01)*(0.03)0.00(0.02)(0.01)*(0.02)(0.01)
Weighted average shares, basic thousands of shares147,706—170,729170,739170,781171,137*178,836193,572193,590193,835*196,008200,136
Weighted average shares, diluted thousands of shares147,843—181,610181,843181,885179,488*188,600202,836202,857200,331*205,310209,423

Balance sheet

CSV

Fiscal quarters (SSII's year ends in late December)

In thousands of dollarsSep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
Cash and cash equivalents6,5962,02294860822046715,87311,3755,6823,20615,98013,647
Accounts receivable1,9831,9014,9654,2803,9134,4663,9625,9746,91712,39914,05416,986
Inventory5,1007,0186,9227,2189,42410,20714,29518,26020,03617,06417,06618,482
Prepaid and other current assets2,2993,8903,6264,2564,7376,4387,6039,2939,76610,19411,53013,690
Total current assets22,71621,42923,59223,26925,08227,41647,62050,78748,42548,80166,26271,454
Property and equipment, net6377062,1762,7753,8025,3867,0448,2748,2509,1018,8318,637
Right-of-use asset2,7592,6582,5522,4492,8032,6242,6292,6552,4592,7542,4993,046
Total assets28,15531,51635,20235,66739,02142,38563,45769,97869,57774,22690,54796,982
Accounts payable7209021,8281,1261,7992,3123,6416,0804,6575,1274,4035,266
Accrued liabilities410144———1,885—3,784————
Current portion of long-term debt499510522—————————
Total current liabilities8,5018,47413,03314,97818,49921,33014,99719,61121,18826,24226,04531,892
Total deposits4,9674,9635,5535,5525,530—————543—
Lease liability, non-current2,4592,3512,2382,1262,4792,3492,4032,4522,2732,3382,0872,550
Total liabilities11,78711,79818,45320,89525,33128,92822,90327,95529,92836,00836,02343,581
Accumulated deficit(12,369)(24,511)(34,353)(38,494)(41,739)(43,663)(49,344)(49,601)(53,319)(55,790)(59,373)(62,034)
Total stockholders' equity16,36819,71816,74914,77213,69013,45740,55442,02339,64938,21854,52353,401
Total liabilities and equity28,15531,51635,20235,66739,02142,38563,45769,97869,57774,22690,54796,982
Common shares outstanding (cover page) thousands of shares169,118170,724170,739170,739170,864193,559193,604193,588193,621194,357200,132200,385

Cash flows

CSV

Fiscal quarters (SSII's year ends in late December)

In thousands of dollarsSep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
Net income (loss)(1,899)(12,142)*(9,842)(4,141)(3,245)(1,923)*(5,681)(257)(3,718)(2,471)*(3,583)(2,661)
Stock-based compensation249,691*7,1092,4442,4512,339*2,3791,6302,0952,023*3,1442,178
Net cash from operating activities(5,591)*(4,403)*(1,249)(2,445)*(2,547)*(3,262)*(6,103)(3,452)*(7,468)*(1,520)*(2,312)(4,235)*
Purchases of property and equipment141*1,886*1,550689*(1,703)*125*873317*755*1,715*54—
Net cash from investing activities(221)*(118)*(1,550)(689)*1,703*(125)*(873)(317)*(755)*(1,715)*(54)(161)*
Proceeds from issuing common stock—year only——————————
Net cash from financing activities16,886*151*2,6382,654*722*3,411*22,406(702)*3,089*1,373*18,1603,479*

Compare with peers

SIC 3841 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen
  • SIC 3841 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
  • Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
  • Runway shows only for companies burning cash with under $10B of public float.
  • * marks a quarter worked out from the filing totals: for a 10-K, the year less the first three quarters; for a 10-Q, the year-to-date total less the earlier one.
  • A cell reading “not reported” means the filings give no figure for that quarter alone.
CompanyCash ($K)Revenue, quarter ($K)Operating cash flow, quarter ($K)Shares outstandingRunwayQuarter
SS Innovations International13,647not reported(4,235)*200.4M3.2 quarters 10-QJun 30, 2026
Venus Concept4,31213,776(4,890)*1.9M0.9 quarters 10-QSep 30, 2025
Treace Medical Concepts12,61045,376(4,698)*65.0M9.7 quarters 10-QJun 30, 2026
Bioventus30,709142,44220,658*not reported— 10-QSep 26, 2026
Mobia Medical177,09013,505(15,670)*33.3M11.3 quarters 10-QJun 30, 2026
NeuroPace12,53822,826(3,903)*34.3M13.2 quarters 10-QJun 30, 2026
SANUWAVE Health9,3769,739425*8.6M— 10-QJun 30, 2026
Cerus16,35057,7143,007*202.0M— 10-QSep 30, 2026
Electromed20,45019,417*2,994*8.4M— 10-KJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.